PV Consultings and Business Opportunity

Due to the changing resources necessary to fulfil the regulatory requirements, some companies also choose to outsource or out task regulatory affairs to external service providers. Regulatory Affairs department is constantly evolving and growing and is the one which is least impacted during the Acquisition and Merger, and also during recession. The global pharmacovigilance market and Business opportunity was valued at USD 2,408.0 million in 2013 and is expected to grow at a CAGR of 12.6% during the forecast period. Phase III clinical trials market was the second largest and was valued at over USD 750.0 million in 2013.

  • Pharmacovigilance software Devlopment Companies
  • Bussiness Opportunities for PV Software Devloping Companies
  • Opportunities for PV Software Services companies
  • Career Growth in PV Consulting

Related Conference of PV Consultings and Business Opportunity

February 01-02, 2024

37th World Congress on Pharmacology

Dubai, UAE
February 22-23, 2024

34th Annual European Pharma Congress

Zurich, Switzerland
April 04-05, 2024

17th European Biosimilars Congress

Madrid, Spain
April 11-12, 2024

5th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France

PV Consultings and Business Opportunity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in